Informing Congress: A Return of the OTA?

In the midst of this summer's rancorous US House of Representatives debate over the legality of cloning, an exasperated Rep. Louise Slaughter (D-N.Y.) complained, "Mr. Speaker, we really should not be debating this at all. None of us is equipped to do so. We simply do not know enough." Rep. Peter Deutsch (D-Fla.) agreed. "In my nine years in this chamber, this is the least informed collectively that the 435 members of this body have ever been on any issue." In the end, the July 31, 265-162 vote

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Rep. Rush Holt (D-N.J.), one of two physicists in Congress, believes the cloning experience highlights the need for better scientific and technical information on Capitol Hill. He has introduced legislation (HR 2148) to bring back the Office of Technology Assessment (OTA), a congressional entity that had provided legislators with information and reports on a variety of scientific and technical topics for more than 20 years. Until it was disbanded in 1995, a victim of politics and budget cuts, OTA employed some 200 staffers and published up to 55 reports per year, some book-length, and had another 30 to 60 projects in progress. OTA's work "ran the gamut of subject matter, with approaches tailored for each topic and congressional request," wrote Rep. Amo Houghton (R-N.Y.), "in memoriam" in 1995. "The agency took on controversial subjects, examining them objectively and comprehensively. It helped us to better understand complex technical issues." Courtesy of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ted Agres

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio